Algert Global LLC Increases Stock Position in Ardent Health, Inc. $ARDT

Key Points

• Algert Global sharply increased its Ardent Health position by 1,277.3% in the second quarter, adding 554,345 shares to own 597,745 shares worth approximately $5.9 million, or 0.42% of the company.
• Institutional interest broadened, with BlackRock initiating a roughly $21.4 million stake and Goldman Sachs, Ameriprise Financial, Goldentree Asset Management, and Bridgeway Capital Management also increasing their holdings.
• Ardent reported quarterly EPS of $0.12, below the $0.18 consensus, though revenue of $1.62 billion exceeded estimates. Analyst sentiment remains mixed, with a consensus “Hold” rating and an average price target of $13.05 versus the stock’s $10.96 opening price.

Algert Global LLC increased its holdings in shares of Ardent Health, Inc. (NYSE:ARDT - Free Report) by 1,277.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 597,745 shares of the company's stock after purchasing an additional 554,345 shares during the quarter. Algert Global LLC owned 0.42% of Ardent Health worth $5,882,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ARDT. BlackRock Inc. bought a new stake in shares of Ardent Health during the 2nd quarter valued at about $21,415,000. Goldentree Asset Management LP boosted its stake in shares of Ardent Health by 99.7% during the 4th quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company's stock worth $20,302,000 after acquiring an additional 1,150,000 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock valued at $10,558,000 after acquiring an additional 724,841 shares during the period. Ameriprise Financial Inc. grew its position in shares of Ardent Health by 75.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company's stock valued at $22,332,000 after acquiring an additional 703,739 shares during the period. Finally, Bridgeway Capital Management LLC increased its stake in shares of Ardent Health by 108.2% in the 4th quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company's stock worth $8,358,000 after purchasing an additional 491,961 shares in the last quarter.

Wall Street Analyst Weigh In

ARDT has been the subject of a number of analyst reports. The Goldman Sachs Group reissued a "neutral" rating and issued a $13.00 price objective on shares of Ardent Health in a research note on Thursday, August 6th. Zacks Research downgraded Ardent Health from a "hold" rating to a "strong sell" rating in a research note on Thursday, August 6th. Truist Financial upped their price target on shares of Ardent Health from $12.00 to $13.00 and gave the company a "buy" rating in a research note on Thursday, August 6th. UBS Group increased their price objective on shares of Ardent Health from $13.00 to $13.50 and gave the company a "buy" rating in a research report on Thursday, May 7th. Finally, Weiss Ratings cut shares of Ardent Health from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 11th. Seven equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $13.05.

Ardent Health Trading Down 2.4%

Shares of NYSE ARDT opened at $10.96 on Friday. Ardent Health, Inc. has a twelve month low of $7.71 and a twelve month high of $15.48. The business has a fifty day simple moving average of $10.51 and a two-hundred day simple moving average of $9.75. The firm has a market cap of $1.55 billion, a PE ratio of 19.94, a price-to-earnings-growth ratio of 3.15 and a beta of 0.70. The company has a quick ratio of 1.99, a current ratio of 2.10 and a debt-to-equity ratio of 0.61.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.The business had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Analysts expect that Ardent Health, Inc. will post 0.97 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Alfred Lumsdaine acquired 10,000 shares of the firm's stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average cost of $8.81 per share, with a total value of $88,100.00. Following the transaction, the chief financial officer directly owned 329,183 shares of the company's stock, valued at $2,900,102.23. This trade represents a 3.13% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.90% of the company's stock.

Ardent Health Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

Want to see what other hedge funds are holding ARDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ardent Health, Inc. (NYSE:ARDT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source